Livanova Office Locations

Livanova has an office in London
London, GB (HQ)
20 Eastbourne Terrace
Show all (1)

Livanova Financials and Metrics

Livanova Revenue

Livanova's revenue was reported to be $1.11 b in FY, 2018
USD

Revenue (Q1, 2019)

250.8m

Net income (Q1, 2019)

(14.8m)

Market capitalization (16-May-2019)

3.5b

Closing stock price (16-May-2019)

73.1

Cash (31-Mar-2019)

50.8m
Livanova's current market capitalization is $3.5 b.
Annual
USDFY, 2016FY, 2018

Revenue

1.2b1.1b

Cost of goods sold

472.0m

Gross profit

741.9m

Gross profit Margin, %

61%
Quarterly
USDQ1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019

Revenue

287.0m321.0m295.3m285.1m321.4m309.7m250.4m287.5m272.1m250.8m

Cost of goods sold

123.6m130.7m106.5m101.5m108.9m108.2m84.6m92.0m94.3m

Gross profit

163.4m190.4m188.8m183.6m212.5m201.4m165.8m195.5m177.8m

Gross profit Margin, %

57%59%64%64%66%65%66%68%65%
Annual
USDFY, 2015FY, 2016FY, 2017FY, 2018

Cash

112.6m39.8m93.6m47.2m

Accounts Receivable

272.4m275.7m282.1m

Inventories

212.4m183.5m144.5m153.5m

Current Assets

673.4m620.1m869.9m533.3m
Quarterly
Annual
USDFY, 2016FY, 2017FY, 2018

Net Income

(62.8m)(25.1m)(189.4m)

Depreciation and Amortization

85.4m82.9m69.9m

Inventories

26.7m7.2m(10.6m)

Cash From Operating Activities

90.2m91.3m120.5m
Quarterly
USDQ1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019

Net Income

(40.4m)(31.4m)(33.0m)11.3m58.8m86.6m13.3m28.3m21.2m(14.8m)

Depreciation and Amortization

23.6m41.7m64.2m20.2m41.1m63.3m17.1m35.2m53.0m16.9m

Inventories

10.8m24.7m20.6m(4.4m)(6.9m)(11.0m)(6.3m)(11.3m)(7.6m)(8.3m)

Cash From Operating Activities

9.6m12.6m49.3m33.2m31.6m73.7m20.4m48.5m99.6m2.0m
USDY, 2019

Financial Leverage

1.7 x
Show all financial metrics

Livanova Online and Social Media Presence

Embed Graph

Livanova News and Updates

Global Heart Valve Repair and Replacement Devices Market to 2023 - Key Vendors are Abbott, Boston Scientific, CryoLife, Edwards Lifesciences, LivaNova, & Medtronic

DUBLIN, May 2, 2019 /PRNewswire/ -- The "Global Heart Valve Repair and Replacement Devices Market 2019-2023" report has been added to ResearchAndMarkets.com's offering. The analysts have predicted that the heart valve repair and replacement devices market will register a CAGR of nearly...

Neuromodulation Market 2023 report provides Latest improvements in the industry by anticipating the future perspective of the market, competitors, the top key players such as Medtronic plc, St. Jude Medical, Inc., LivaNova PLC

The Global Neuromodulation Market is an analysis and portrayal of the market globally. It gives a clear image of the market and a thoughtful knowledge about its segments. The various sections are examined and is the key part of the Neuromodulation Market. Posted via Industry Today. Follow us on Twit…

Cardiopulmonary Bypass Equipment Market Expected to Witness the Highest Growth 2026 | With Global Key Players Medtronic Plc, LivaNova PLC, MAQUET Holding B.V. & Co. KG., Terumo Corporation, Braile Biomedica, Tianjin Medical

Cardiopulmonary bypass equipment is a machine which takes over the function of heart and lungs to maintain the circulation of blood and the oxygen content of the patient's body during coronary bypass heart surgery. Posted via Industry Today. Follow us on Twitter @IndustryToday

Global Cardiac Prosthetic Devices Market Attractiveness, Competitive Landscape and Key Players Boston scientific, Medtronic, Livanova, Edward lifesciences, ST.jude medical, Elkem Silicones, Integer Holdings Corporation, Getinge AB

Market research Report on Cardiac Prosthetic Devices industry providing global and Chinese Market Landscape and its Growth Prospects over the approaching years until 2025 is currently offered at The Insight Partners Posted via Industry Today. Follow us on Twitter @IndustryToday

Global Annuloplasty Rings Market Is Expected To Reach Usd 492.65 Million By 2022 Along With The Keyplayers As Medtronic, Edwards Lifesciences Corporation, Abbott, Livanova Plc, Braile Biomédica, Labcor Laboratórios Ltda

Qurate Business Intelligence added “Breast Implants Market” to its research database with information such as company profiles, product picture and specification. Posted via Industry Today. Follow us on Twitter @IndustryToday

Global Cannula Market Analysis & Forecast Report 2018-2025 Featuring Innovators - Smith and Nephew, Smiths Medical, Teleflex & Livanova

DUBLIN, Oct. 30, 2018 /PRNewswire/ -- The "Cannula Market Size, Share & Trends Analysis Report By Product (Dermatology, Cardiac, Nasal), By Type, By Material, By Size, By End Use (Hospital, ASC), And Segment Forecasts, 2018 - 2026" report has been added to ResearchAndMarkets.com's...

Livanova Frequently Asked Questions

  • When was Livanova founded?

    Livanova was founded in 2015.

  • How many employees does Livanova have?

    Livanova has 4,000 employees.

  • What is Livanova revenue?

    Latest Livanova annual revenue is $1.1 b.

  • What is Livanova revenue per employee?

    Latest Livanova revenue per employee is $276.7 k.

  • Who are Livanova competitors?

    Competitors of Livanova include C. R. Bard, Integra LifeSciences and Teleflex.

  • Where is Livanova headquarters?

    Livanova headquarters is located at 20 Eastbourne Terrace, London.

  • Where are Livanova offices?

    Livanova has an office in London.

  • How many offices does Livanova have?

    Livanova has 1 office.